Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
93.93
-1.03 (-1.08%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Zimmer Biomet Holdings Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, Zimmer Biomet Holdings stock has a consensus rating of "Buy" and an average price target of $99.38. The average 1-year stock price forecast is 5.80% higher than the current stock price, while the lowest is $83 (-11.64%) and the highest is $130 (+38.40%).

Price Target: $99.38 (+5.80%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$83$99.38$95$130
Change-11.64%+5.80%+1.14%+38.40%

Analyst Ratings

The average analyst rating for Zimmer Biomet Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy666667
Buy322222
Hold171717171718
Sell111000
Strong Sell211110
Total292727262627

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Upgrades
$89$115
BuyUpgrades$89$115+22.43%Jul 28, 2026
BTIG
BTIG
Hold
Maintains
n/a
HoldMaintainsn/an/aJul 23, 2026
RBC Capital
RBC Capital
Buy
Maintains
$101
BuyMaintains$101+7.53%Jul 14, 2026
BMO Capital
BMO Capital
Hold
Initiates
$95
HoldInitiates$95+1.14%Jul 9, 2026
Citi
Citi
Hold
Maintains
$93
HoldMaintains$93-0.99%Jul 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
8.55B
from 8.23B
Increased by 3.81%
Revenue Next Year
8.85B
from 8.55B
Increased by 3.51%
EPS This Year
8.47
from 8.20
Increased by 3.32%
EPS Next Year
9.00
from 8.47
Increased by 6.27%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
6.83B6.94B7.39B7.68B8.23B8.55B
Revenue Growth
11.42%1.65%6.55%3.85%7.20%3.81%
Gross Profit
4.87B4.92B5.32B5.50B5.74B6.08B
Gross Margin
71.29%70.90%71.93%71.61%69.71%71.18%
Operating Income
1.22B1.29B1.51B1.59B1.40B2.31B
Net Income
401.60M231.40M1.02B903.80M705.10M925.94M
EPS
----8.208.47
EPS Growth
----2.50%3.32%
Forward PE
16.4018.6315.4712.5210.7211.09
Dividend / Share
0.960.960.960.960.960.99
Dividend Growth
-----3.35%
Free Cash Flow
891.55M1.65B1.13B1.06B1.35B1.29B
No. Analysts
-----26
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High8.6B
Avg8.5B
Low8.4B

Revenue Growth

Revenue Growth202620272028
High
4.6%
Avg
3.8%
Low
2.3%

EPS Forecast

EPS202620272028
High8.53
Avg8.47
Low8.29

EPS Growth

EPS Growth202620272028
High
4.0%
Avg
3.3%
Low
1.1%